StarTribune.com
us pfizer research reorg glance 110909

Home | Business

Pfizer announces plans for research and development facilities as it integrates Wyeth's sites

Last update: November 9, 2009 - 5:23 PM

Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one. Following is a list of the sites:

Former Wyeth sites staying open/Types of future research:

_ Collegeville, Pa. - some vaccine research continuing, but most other research moving out

_ Pearl River, N.Y. - vaccines, biotech drugs and traditional medicines

_ Andover, Mass. - biotech drugs

_ Cambridge, Mass. - vaccines, biotech drugs and traditional medicines

_ Aberdeen, Scotland - biotech drugs

_ Montreal - various R&D

Pfizer sites staying open/Types of future research:

_ La Jolla, Calif. - vaccines, biotech drugs and traditional medicines

_ San Francisco - antibody-based biotech drugs

_ Groton, Conn. - vaccines, biotech drugs and traditional medicines

_ St. Louis, Mo. - biotech drugs, but with sharply reduced staff

_ Sandwich, U.K. - vaccines, biotech drugs and traditional medicines

_ Shanghai, China - various R&D

_ Cambridge, U.K. - regenerative medicine (repairing damaged tissue)

_ Cambridge, Mass. - various R&D

_ Dusseldorf, Germany - various R&D

Sites Being Closed (all Wyeth facilities):

_ Princeton, N.J.

_ Chazy, N.Y.

_ Plattsburgh/Rouses Point, N.Y.

_ Gosport, U.K.

_ Research Triangle Park, N.C.

_ Sandford, N.C.

___

Source: Pfizer Inc..

Recent Business stories

Prosecutor jabs, Petters takes to ropes - November 9, 2009
Prosecutor jabs, Petters takes to ropes - In the main event of Tom Petters' fraud trial, the defendant mostly bobbed and weaved as the prosecutor went bare knuckles. More

Comment on this story   |   Be the first to comment   |  Hide reader comments

Subscribe

Blog: Patent Pending

Lights out at U energy conference. Irony police notified.

Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.

Recent posts